C1QTNF4 has been shown to influence NF-κB activation (22), a pathway known to be implicated in SLE pathogenesis, therefore we looked for an effect of the p.His198Gln mutation on NF-κB production. Here, C1QTNF4 is linked to systemic lupus erythematosus.